Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 492-498, January 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vater, S. T.
Right arrow Articles by Warshawsky, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vater, S. T.
Right arrow Articles by Warshawsky, D.

Hepatic Metabolism of 7,12-Dimethylbenz(a)anthracene in Male, Female, and Ovariectomized Sprague-Dawley Rats1

Sarah T. Vater2, David M. Baldwin3 and David Warshawsky4

Departments of Environmental Health [S. T. V. and D. W.] and Physiology and Bioophysics [D. M. B], Kettering Laboratory, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0056

Dimethylbenz(a)anthracene (DMBA) is a potent inducer of mammary tumors in intact female Sprague-Dawley rats, but not in males or ovariectomized females (OVX). Qualitative and quantitative aspects of hepatic metabolism of DMBA were examined in these three groups of rats, using the nonrecirculating perfused liver, to determine whether the production of proximate carcinogenic metabolites of DMBA by the liver differed among these groups in the same manner as does sensitivity to tumor induction.

DMBA was infused into the liver at a constant rate for 60 min. Rates of appearance of DMBA and its metabolites were measured in perfusate and bile during the infusion period and the first 60 min thereafter. The maximum rate of appearance of total metabolites in the perfusate, seen at the end of the infusion period, was highest in the intact female [2.6 ± 0.3 nmol/(g x min)], slightly lower in the OVX [2.3 ± 0.2 nmol/(g x min)] and significantly lower in the male [1.0 ± 0.1 nmol/(g x min)]. The rates of appearance of metabolites in the bile showed the same order as those seen in the perfusate.

The major metabolites extracted from the perfusate in all three groups were dihydrodiols, hydroxymethyl metabolites, and several unidentified metabolites. The 3,4-dihydrodiol, a proximate carcinogenic metabolite, appeared in the perfusate at higher rates in the intact female and OVX than in the male. Hydrolysis of bile samples showed that glucuronidation was a major pathway in the excretion of DMBA metabolites in bile. High performance liquid chromatographic analysis indicated that hydrolysis of DMBA glucuronides yielded the 7- and 12-hydroxymethyl metabolites and an unidentified metabolite designated X. The major hydrolysis product in the male was 12-hydroxymethyl while X was found to be the major product in the intact female and OVX.

Under the conditions of this study, there were differences in the metabolic activation of DMBA by male and female rat liver. Ovariectomy, followed by DMBA perfusion 7 days later, did not result in significant changes in DMBA metabolism relative to the intact female, except for a decreased rate of excretion of metabolites in bile.

1 Research sponsored by the American Cancer Society, Ohio Division.

2 Recipient of a graduate training fellowship awarded by the National Science Foundation Graduate Fellowship Program (RCD-8450052). Present address: Syracuse Research Corporation, Cincinnati, OH.

3 Permanent address: Department of Reproduction, University of California, School of Veterinary Medicine, Davis, CA 95616.

4 To whom requests for reprints should be addressed.

Received 5/31/90. Accepted 10/25/90.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.